# US 2001/0025041 A1 · Amidino protease inhibitors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0025041 A1
- Document ID: US20010025041A1
- Status: Published application
- Kind: A1
- Application number: 09/851,123
- Filed: 2001-05-09
- Published: 2001-09-27
- Earliest claimed: 1995-12-29
- Assignees: 3-Dimensional Pharmaceuticals, Inc.
- Inventors: Tianbao Lu; Bruce E. Tomczuk; Carl R. Illig; Richard M. Soll
- Web page: https://patentgrep.com/patent/US20010025041A1

## CPC

- C07D 295/195: Radicals derived from nitrogen analogues of carboxylic acids
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/18: for pancreatic disorders, e.g. pancreatic enzymes
- A61P 7/00: Drugs for disorders of the blood or the extracellular fluid
- A61P 7/02: Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07C 309/73: to carbon atoms of non-condensed six-membered aromatic rings
- C07C 311/21: having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07D 211/22: by oxygen atoms
- C07D 211/26: with hydrocarbon radicals, substituted by nitrogen atoms
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

Amidino and benzamidino compounds, including compounds of the formula: 1 wherein R1-R4, R6-R9, Y, Z, n and m are set forth in the specification, as well as hydrates, solvates or pharmaceutically acceptable salts thereof, that inhibit a number of proteolytic enzymes are described. Also described are methods for preparing the compounds of Formula I.

## Claims

### Claim 1

A compound having the Formula I: 11
or solvates, hydrates or pharmaceutically acceptable salts thereof; wherein:
Z is one of —NR10SO2—, —SO2NR10—, —NR10C(RyRz)—, —C(RyRz)NR10—, —OSO2—, —SO2O—, —OC(RyRz)—, —C(RyRz)O—, -NR10CO— or —CONR10—;
Ry and Rz are each independently one of hydrogen, alkyl, cycloalkyl, aryl, aralkyl, hydroxyalkyl, carboxyalkyl, aminoalkyl, monoalkylaminoalkyl, dialkylaminoalkyl or carboxy;
R1 is one of alkyl, cycloalkyl, alkenyl, allynyl, aryl, aralkyl or heteroaryl, any of which may be optionally substituted;
R2, R3 and R4 are each independently one of hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl, aryl, aralkyl, heteroaryl, trifluoromethyl, halogen, hydroxyalkyl, cyano, nitro, carboxamide, —CO2Rx, —CH2ORx or —ORx, or when present on adjacent carbon atoms, R2 and R3 may also be taken together to form one of —CH=CH—CH=CH— or —(CH2)q—, where q is from 2 to 6, and R4 is defined as above;
Rx, in each instance, is independently one of hydrogen, alkyl or cycloalkyl wherein said alkyl or cycloalkyl groups may optionally have one or more unsaturations;
Y is one of —O—, —NR10—, —S—, —CHR10— or a covalent bond;
W is N or CR10;
R6, in each instance, is independently one of hydrogen, alkyl, hydroxy, alkoxy, aryloxy, aralkoxy, alkoxycarbonyloxy, cyano or —CO2Rw, where RW is alkyl or cycloalkyl;
R7 and R8 are each independently one of hydrogen, alkyl, aralkyl, aryl, hydroxyalkyl or carboxyalkyl, or R7 and R8 are taken together to form —CH2)y—, where y is zero, 1 or 2, with the proviso that when W is N, y cannot be zero or 1;
R9 is one of hydrogen, alkyl, cycloalkyl or aryl, wherein said alkyl, cycloalkyl or aryl can be optionally substituted with amino, monoalkylamino, dialkylamino, alkoxy, hydroxy, carboxy, alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, aryl, heteroaryl, acylamino, cyano or trifluoromethyl;
R10, in each instance, is independently one of hydrogen, alkyl, aralkyl, aryl, hydroxyalkyl, aminoalkyl, monoalkylamino(C2-10)alky1, dialkylamino (C2-10)alkyl or carboxyalkyl;
n is from zero to 8, with the proviso that when W is N and Y is other than —CHR10—, then n is from 2 to 8; and
m is from 1 to 4, provided that when W is N, then m is not 1.

### Claim 2 (depends on 1)

A compound of claim 1, wherein:
Z is one of —SO2O—, —SO2NR10—, (RyRz)O— or —OC(RyRz), where Ry and Rz are each hydrogen;
R1 is one of C6-10 aryl, pyridinyl, quinizolinyl, quinolinyl or tetaahydroquinolinyl, any of which is optionally substituted by one or two of hydroxy, nitro, trifluoromethyl, halogen, C1-6 alkyl, C1-6 alkoxy, C1-6 arninoalkyl, C1-6 aminoalkoxy, amino, mono(C1-4)alkylamino, di(C1-4)alkylamino, C2-6 alkoxycarbonylamino, C2-6 alkoxycarbonyl, carboxy, C1-6 hydroxyalkyl, C2-6 hydroxyalkoxy, C2-10 mono(carboxyalkyl)amino, di(C2-10 carboxyalkyl)amino, C6-14 ar(C1-6 alkoxycarbonyl, C2-6 alkynylcarbonyl, C1-6 alkylsulfonyl, C2-6 alkenylsulfonyl, C2-6 alkynylsulfonyl, C1-6 alkylsulfinyl, C1-6 alkylsulfonamido, amidino, guanidino, C1-6 alkyliminoamino, formyliminoamino, C2-6 carboxyalkyl, C2-6 carboxyalkoxy, C2-6 carboxyalkylamino, cyano, trifluoromethoxy, or perfluoroethoxy;
R2, R3 and R4 are independently one of hydrogen, C1-6 alkyl, C3-8 cycloalkyl, phenyl, benzyl, trifluoromethyl, halogen, hydroxy(C1-8)alkyl, cyano, nitro, carboxamide, carboxy, C1-4 alkoxycarbonyl, C1-4 alkoxymethyl or C1-4 alkoxy; or alternatively, R2 and R3, when present on adjacent carbon atoms, may also be taken together to form one of —CH=CH—CH=CH— or —CH2)q—, where q is from 2 to 6, and R4 is as defied above;
Y is one of —O—, —S—, —NR10—, or a covalent bond;
W is N or CR10;
R6, in each instance, is one of hydrogen, C1-4 alkyl, hydroxy, C1-4 alkoxy, phenoxy, C1-4 alkyloxycarbonyl or cyano;
R7 and R8 are independently one of hydrogen, C1-6 alkyl, C2-10 carboxyalkyl or C2-10 hydroxyalkyl, or R7 and R8 are taken together to form —(CH2)y— where y is 0, 1 or 2, provided that when W is N, y cannot be 0 or 1;
R9 is hydrogen; or C1-10 alkyl, optionally substituted with amino, mono(C1-4)alkylamino, C1-6 alkoxy, hydroxy, carboxy, phenyl, alkyloxycarbonyl, aralkoxycarbonyl, C1-6 acylamino, cyano or trifluoromethyl;
R10, in each instance, is independently hydrogen, C1-6 alkyl, benzyl, phenyl, C2-10 hydroxyalkyl, C2-10 arinoalkyl, C1-4 monoalkylamio(C2-8)alkyl, C1-4 dialkylamino(C2-8)alkyl or C2-10 carboxyalkyl;
n is from zero to 8, with the proviso that when W is N, then n is from 2 to 8; and
m is from 1 to 4, provided that when W is N, then m is not 1.

### Claim 3 (depends on 1)

A compound of claim 1, wherein:
Z is one of —SO2O—, —SO2NR10—, —CH2O— or —OCH2—;
R1 is one of phenyl or naphthyl, optionally substituted by one or two of chloro or dimethylamino;
R2 and R3 are each hydrogen or R2 and R3 may also be taken together to form —CH=CH—CH=CH—;
R4 is one of hydrogen, methyl, methoxy or trifluoromethyl;
Y is one of O or NR10;
W is N or CR10;
R6, in each instance is hydrogen or hydroxy;
R7 and R8 are independently one of hydrogen, C1-6 alky, C2-10 hydroxyalkyl or C2-10 carboxyalkyl, or R7 and R8 are taken together to form —(CH2)y—, where y is zero, 1 or 2, with the proviso that when W is N, y cannot be zero or 1;
R9 is hydrogen or C1-4 alkyl;
R10, in each instance, is independently hydrogen, C1-4 alkyl, C2-4 hydroxyalkyl, C2-4 carboxyalkyl, C2-4 aminoalkyl, dimethylamino(C2-8)alkyl, methylamino(C2-8)alkyl;
n is from zero to 4, with the proviso that when W is N, then n is 2 to 4; and m is 1, 2or3.

### Claim 4

A compound having the Formula II: 12
or solvates, hydrates or pharmaceutically acceptable salts thereof; wherein:
Z is one of —NR10SO2—, —SO2NR10—, —NR10C(RyRz)—, —C(RyRz)NR10—, —OSO2—, —SO2O—, —OC(RyRz)—, —C(RyRz)O—, —NR10CO— or —CONR10—;
Ry and Rz are each independently one of hydrogen, alkcyl, cycloalkyl, aryl, aralkyl, hydroxyalkyl, carboxyalkyl, aminoalkyl, monoalkylaminoalkyl, dialkylaminoalkyl or carboxy;
R1 is one of alkyl, cycloalkyl, alkenyl, alkynyl, aryl, aralkyl or heteroaryl, any of which may be optionally substituted;
R2, R3 and R4 are each independently one of hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl, aryl, aralkyl, heteroaryl, trifluoromethyl, halogen, hydroxyalkyl, cyano, nitro, carboxamide, —CO2Rx, —CH2ORx or —ORx, or when present on adjacent carbon atoms, R2 and R3 may also be taken together to form one of —CH=CH—CH=CH— or —(CH2)q—, where q is from 2 to 6, and R4 is defined as above;
Rx, in each instance, is independently one of hydrogen, alkyl or cycloalkyl wherein said alkyl or cycloalkyl groups may optionally have one or more unsaturations;
Y is one of —O—, —NR10—, —S—, —CHR10— or a covalent bond;
W is N or CR10;
R6, in each instance, is independently one of hydrogen, alkyl, hydroxy, alkoxy, aryloxy, aralkoxy, alkoxycarbonyloxy, cyano or —CO2Rw, where Rw is alkyl or cycloalkyl;
R7 and R8 are each independently one of hydrogen, alkyl, aralkyl, aryl, hydroxyalkyl or carboxyalkyl, or R7 and R8 are taken together to form —(CH2)y—, where y is zero, 1 or 2, with the proviso that when W is N, y cannot be zero or 1;
R10, in each instance, is independently one of hydrogen, alkyl, aralkyl, aryl, hydroxyalkyl, aminoalkyl, monoalkylamino(C2-10)alkyl, dialkylamino (C2-10)alkyl or carboxyalkyl;
n is from zero to 8, with the proviso that when W is N and Y is other than —CHR10—, then n is from 2 to 8; and
m is from 1 to 4, provided that when W is N, then m is not 1.

### Claim 5 (depends on 4)

A compound of claim 4, wherein:
Z is one of —SO2O—, —SO2NR10—, C(RyRz)O— or —OC(RyRz)—, where Ry and Rz are each hydrogen;
R1 is one of C6-10 aryl, pyridinyl, quinizolinyl, quinolinyl or tetrahydroquinolinyl, any of which is optionally substituted by one or two of hydroxy, nitro, trifluoromethyl, halogen, C1-6 alkyl, C1-6 alkoxy, C1-6 aminoalkyl, C1-6 aminoalkoxy, amino, mono(C1-4)alkylamino, di(C1-4)alkylamino, C2-6 alkoxycarbonylamino, C2-6 alkoxycarbonyl, carboxy, C1-6 hydroxyalkyl, C2-6 hydroxyalkoxy, C2-10 mono(carboxyalkyl)amino, di(C2-10 carboxyalkyl)amino, C6-14 ar(C1-6)alkoxycarbonyl, C2-6 alkynylcarbonyl, C1-6 alkylsulfonyl, C2-6 alkenylsulfonyl, C2-6 alkynylsulfonyl, C2-6 alkylsulfinyl, C1-6 alkylsulfonamido, amidino, guanidino, C1-6 alkyliminoamino, formyliminoamino, C2-6 carboxyalkoxy, C2-6 carboxyalkyl, C2-6 carboxyalkylamino, cyano, trifluoromethoxy, or perfluoroethoxy;
R2, R3 and R4 are independently one of hydrogen, C1-6 alkyl, C3-8 cycloalkyl, phenyl, benzyl, trifluoromethyl, halogen, hydroxy(C1-8)alkyl, cyano, nitro, carboxamide, carboxy, C1-4 alkoxycarbonyl, C1-4 alkoxymethyl or C1-4 alkoxy; or alternatively, R2 and R3, when present on adjacent carbon atoms, may also be taken together to form one of —CH=CH—CH=CH— or —(CH2)q—, where q is from 2 to 6, and R4 is as defined above;
Y is one of —O—, —S—, —NR10— or a covalent bond;
W is N or CR10;
R6, in each instance, is one of hydrogen, C1-4 alkyl, hydroxy, C1-4 alkoxy, phenoxy, C1-4 alkyloxycarbonyl or cyano;
R7 and R8 are independently one of hydrogen, C1-6 alkyl, C2-10 carboxyalkyl or C2-10 hydroxyalkyl, or R7 and R8 are taken together to form —CH2)y— where y is 0, 1 or 2, provided that when W is N, y cannot be 0 or 1;
R10, in each instance, is independently hydrogen, C1-6 alkyl, benzyl, phenyl, C2-10 hydroxyalkyl, C2-10 aminoalkyl, C1-4 monoalkylammo(C2-8)alkyl, C1-4 dialkylamino(C2-8)alkyl or C2-10 carboxyalkyl;
n is from zero to 8, with the proviso that when W is N, then n is from 2 to 8; and
m is from 1 to 4, provided that when W is N, then m is not 1.

### Claim 6 (depends on 4)

A compound of claim 4, wherein:
Z is one of —SO2O—, —SO2NR10—, —CH2O — or —OCH2—;
R1 is one of phenyl or naphthyl, optionally substituted by one or two of chloro or dimethylamino;
R2 and R3 are each hydrogen or R2 and R3 may also be taken together to form —CH=CH—CH=CH—;
R4 is one of hydrogen, methyl, methoxy or trifluoromethyl;
Y is one of O or NR10;
W is N or CR10;
R6, in each instance is hydrogen or hydroxy;
R7 and R8 are independently one of hydrogen, C1-6 alkyl, C2-10 hydroxyalkyl or C2-10 carboxyalkyl, or R7 and R8 are taken together to form —CH2)y—, where y is zero, 1 or 2, with the proviso that when W is N, y cannot be zero or 1;
R10, in each instance, is independently hydrogen, C1-4 alkyl, C2-4 hydroxyalkyl, C2-4 carboxyalkyl, C2-4 aminoalkyl, dimethylamino(C2-8)alkyl, methylamino(C2-8)alkyl;
n is from zero to 4, with the proviso that when W is N, then n is 2 to 4; and m is 1, 2or 3.

### Claim 7

A compound having the Formula III: 13
or solvates, hydrates or pharmaceutically acceptable salts thereof; wherein:
Z is one of —NR10SO2—, —SO2NR10—, —NR10C(RyRz)—, —C(RyRz)NR10—, —OSO2—, —SO2O—, —OC(RyRz)O—, —C(RyRz)O—, —NR10CO— or —CONR10;
Ry and Rz are each independently one of hydrogen, alkyl, cycloalkyl, aryl, aralkyl, hydroxyalkyl, carboxyalkyl, aminoalkyl, monoalkylaminoalkyl, dialkylaminoalkyl or carboxy;
R1 is one of alkyl, cycloalkyl, alkenyl, alkynyl, aryl, aralkyl or heteroaryl, any of which may be optionally substituted;
R2, R3 and R4 are each independently one of hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl, aryl, aralkyl, heteroaryl, trifluoromethyl, halogen, hydroxyalkyl, cyano, nitro, carboxamide, —CO2Rx, CH2ORx or —ORx, or when present on adjacent carbon atoms, R2 and R3 may also be taken together to form one of —CH=CH—CH=CH— or —(CH2)q—, where q is from 2 to 6, and R4 is defined as above;
Rx, in each instance, is independently one of hydrogen, alkyl or cycloalkyl wherein said alkyl or cycloalkyl groups may optionally have one or more unsaturations;
Y is one of —O—, —NR10—, —S—, —CHR10— or a covalent bond;
W is N or CR10;
R5 is one of hydrogen, alkyl, aralkyl, aryl, hydroxyalkyl or carboxyalkyl;
R6, in each instance, is independently one of hydrogen, alkyl, hydroxy, alkoxy, aryloxy, aralkoxy, alkoxycarbonyloxy, cyano or —CO2Rw, where Rw is alkyl or cycloalkyl;
R10, in each instance, is independently one of hydrogen, alkyl, aralkyl, aryl, hydroxyalkyl, aminoalkyl, monoalkylamino(C2-10)alkyl, dialkylarnino(C2-10)alkyl or carboxyalkyl;
R′ is one of hydrogen, alkyl, cycloalkyl, aryl, aralkyl, heteroaryl, trifluoromethyl, halogen, hydroxyalkyl, cyano, nitro, carboxamide, carboxy, alkoxycarbonyl or alkoxyalkyl; and
n is from zero to 8, with the proviso that when W is N and Y is other than —CHR10—, then n is from 2 to 8.

### Claim 8 (depends on 7)

A compound of claim 7, wherein:
Z is one of —SO2O—, —SO2NR10—, —C(RyRz)O— or —OC(RyRz)—, where Ry and Rz are each hydrogen;
R1 is one of C6-10 aryl, pyridinyl, quinizolinyl, quinolinyl or tetrahydroquinolinyl, any of which is optionally substituted by one or two of hydroxy, nitro, trifluoromethyl, halogen, C1-6 alkyl, C1-6 alkoxy, C1-6 aminoalkyl, C1-6 aminoalkoxy, amino, mono(C1-4)alkylamino, di(C1-4)alkylamino, C2-6 alkoxycarbonylamino, C2-6 alkoxycarbonyl, carboxy, C1-6 hydroxyalkyl, C2-6 hydroxyalkoxy, C2-10 mono(carboxyalkyl)amino, di(C2-10 carboxyalkyl)amino, C6-14 ar(C1-6 alkoxycarbonyl, C2-6 alkynylcarbonyl, C1-6 alkylsulfonyl, C2-6 alkenylsulfonyl, C2-6 alkynylsulfonyl, C1-6 alkylsulfinyl, C1-6 alkylsulfonamido, amidino, guanidino, C1-6 alkyliminoamino, formyliminoamino, C2-6 carboxyalkyl, C2-6 carboxyalkoxy, C2-6 carboxyalkylamino, cyano, trifluoromethoxy, or perfluoroethoxy;
R2, R3 and R4 are independently one of hydrogen, C1-6 alkyl, C3-8 cycloalkyl, phenyl, benzyl, trifluoromethyl, halogen, hydroxy(C1-8)alkyl, cyano, nitro, carboxamide, carboxy, C1-4 alkoxycarbonyl, C1-4 alkoxymethyl or C1-4 alkoxy; or alternatively, R2 and R3, when present on adjacent carbon atoms, may also be taken together to form one of —CH=CH—CH=CH— or —(CH2)q—, where q is from 2 to 6, and R4 is as defined above;
Y is one of —O—, —S—, —NR10 — or a covalent bond;
W is N or CR10;
R5 is one of hydrogen, C1-4 alkyl, C2-10 carboxyalkyl or C2-10 hydroxyalkyl;
R6, in each instance, is one of hydrogen, C1-4 alkyl, hydroxy, C1-4 alkoxy, phenoxy, C1-4 alkyloxycarbonyLor cyano;
R10, in each instance, is independently hydrogen, C1-6 alkyl, benzyl, phenyl, C2-10 hydroxyalkyl, C2-10 aminioalkyl, C1-4 monoalkylamino(C2-8)alkyl, C1-4 dialkylamino(C20-8)alkyl or C2-10 carboxyalkyl;
R′ is one of hydrogen, C1-6 alkyl, C3-8 cycloalkyl, phenyl, benzyl, trifluoromethyl, halogen, hydroxy(C1-8)alkyl, cyano, nitro, carboxamide, carboxy, alkoxycarbonyl, alkoxymethyl or alkoxy; and
n is from zero to 8, with the proviso that when W is N, then n is from 2 to 8.

### Claim 9 (depends on 7)

A compound of claim 7, wherein:
Z is one of —SO2O—, —SO2NR10—, CH2O— or —OCH2—;
R1 is one of phenyl or naphthyl, optionally substituted by one or two of chloro or dimethylamino;
R2 and R3 are each hydrogen or R2 and R3 may also be taken together to form —CH=CH—CH=CH—;
R4 is one of hydrogen, methyl, methoxy or trifluoromethyl;
Y is one of O or NR10;
W is N or CR10;
R5 is one of hydrogen, C1-6 alkyl, C2-10 hydroxyalkyl or C2-10 carboxyalkyl;
R6, in each instance is hydrogen or hydroxy;
R10, in each instance, is independently hydrogen, C1-4 alkyl, C2-4 hydroxyalkyl, C2-4 carboxyalkyl, C2-4 aminoalkyl, dimethylamino(C2-8)alkyl, methylamino(C2-8)alkyl;
R′ is hydrogen, methyl, methoxy or trifluoromethyl; and
n is from zero to 4, with the proviso that when W is N, then n is 2 to 4.

### Claim 10 (depends on 1)

The compound of claim 1, which is:
chlorobenzenesulfonic acid 3-[(1-acetimidoylpiperidin-4-yl)methoxy]-5-methylphenyl ester hydrochloride;
3-(2-chlorobenzyloxy)-5-methyl-1 -[2-[(1 -acetimidoyl)piperazin-4-yl]]ethoxybenzene diacetic acid salt;
N-[2-(N,N-dimethylamino)ethyl]-N-[2-[[4-(1-acetimidoyl)amino]butoxy]-4-methylphenyl]benzenesulfonamide dihydrochloride;
N-benzyl-N-[[[3-(1-acetimidoyl)piperidin-4-yl]methylamino]phenyl]-benzenesulfonamide;
3-chlorobenzenesulfonic acid 3-[[(1-acetimidoyl)piperidin-4-yl]methoxy]-5-methylphenyl ester hydrochloride;
2,3-dichlorobenzenesulfonic acid 3-[[(1-acetimidoyl)piperidin-4-yl]methoxy]-5-methylphenyl ester hydrochloride;
2-chloro-N-[[3-[(1-acetimidoyl)piperidin-4-yl]methoxy]-5-trifluoromethylphenyl]benzenesulfonamide hydrochloride;
2-chloro-N-(5-carboxypentyl)-N-[[3-[(1-acetimidoyl)piperidin-4-yl]methoxy]-5-trifluoromethylphenyl]benzenesulfonamide;
1-5-(N,N-dimethylamino)naphthalenesulfonic acid 3-[[(l -acetimidoyl)piperidin-3-yl]methoxy]-5-methoxyphenyl ester hydrochloride;
2-chlorobenzenesulfonic acid 1-[[(1-acetimidoyl)piperidin-4-yl]methoxy]naphthalen-3-yl ester acetic acid salt; or
3-[(2-chlorophenoxy)methyl]-[[(1-acetimidoyl)piperidin-4-yl]methoxy]benzene acetic acid salt.

### Claim 11 (depends on 4)

The compound of claim 4, which is:
2-chlorobenzenesulfonic acid 3-[3-amidinopropoxy]-5-methylphenyl ester hydrochloride; or
2-chlorobenzenesulfonic acid 3-[5-amidinopentyloxy]-5-methylphenyl ester acetic acid salt.

### Claim 12 (depends on 7)

The compound of claim 7, which is:
2-chlorobenzenesulfonic acid 3-[(3-amidinophenyl)methoxy]-5-methylphenyl ester hydrochloride;
2-chlorobenzenesulfonic acid 3-[[3-(N-hydroxy)amidinophenyl]methoxy]-5-methylphenyl ester hydrochloride;
2-chlorobenzenesulfonic acid 3-[[3-(N-methylamidino)phenyl]methoxy]-5-methylphenyl ester hydrochloride;
2-chlorobenzenesulfonic acid 3-[(4-amidinophenyl)methoxy]-5-methylphenyl ester hydrochloride; or
2-chlorobenzenesulfonic acid 3-[(3-amidinophenyl)methoxy]phenyl ester hydrochloride.

### Claim 13 (depends on 1)

A pharmaceutical composition for inhibiting proteolysis in a mammal, comprising an amount of a compound of claim 1 effective to inhibit proteolysis.

### Claim 14 (depends on 13)

The pharmaceutical composition of claim 13 further comprising a pharmaceutically acceptable carrier or diluent.

### Claim 15 (depends on 1, 13)

The pharmaceutical composition of claim 13, comprising an amount of a compound of claim 1 effective to inhibit a trypsin-like protease.

### Claim 16 (depends on 13)

A method of inhibiting proteolysis in a mammal, comprising administering to the mammal a composition of claim 13.

### Claim 17 (depends on 16)

The method of claim 16, wherein a trypsin-like protease is inhibited.

### Claim 18 (depends on 13)

A method of treating pancreatitis, thrombosis, ischemia, stroke, restenosis, emphysema or inflammation in a mammal, comprising administering to the mammal a composition of claim 13.

### Claim 19 (depends on 13)

A method of inhibiting thrombin-induced platelet aggregation and clotting of fibrinogen in plasma, comprising administering to the mammal a composition of claim 13.
